Nanhua Bio (China) Price Prediction
| 000504 Stock | 10.07 0.09 0.89% |
Oversold Vs Overbought
64
Oversold | Overbought |
Quarterly Earnings Growth (0.84) | Quarterly Revenue Growth 0.051 |
Using Nanhua Bio hype-based prediction, you can estimate the value of Nanhua Bio Medicine from the perspective of Nanhua Bio response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Nanhua Bio to buy its stock at a price that has no basis in reality. In that case, they are not buying Nanhua because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Nanhua Bio after-hype prediction price | CNY 10.07 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Nanhua |
Nanhua Bio After-Hype Price Prediction Density Analysis
As far as predicting the price of Nanhua Bio at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Nanhua Bio or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Nanhua Bio, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Nanhua Bio Estimiated After-Hype Price Volatility
In the context of predicting Nanhua Bio's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Nanhua Bio's historical news coverage. Nanhua Bio's after-hype downside and upside margins for the prediction period are 5.58 and 14.56, respectively. We have considered Nanhua Bio's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Nanhua Bio is slightly risky at this time. Analysis and calculation of next after-hype price of Nanhua Bio Medicine is based on 3 months time horizon.
Nanhua Bio Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Nanhua Bio is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Nanhua Bio backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Nanhua Bio, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.87 | 4.49 | 0.00 | 0.28 | 0 Events / Month | 1 Events / Month | In 5 to 10 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
10.07 | 10.07 | 0.00 |
|
Nanhua Bio Hype Timeline
Nanhua Bio Medicine is presently traded for 10.07on Shenzhen Stock Exchange of China. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.28. Nanhua is forecasted not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is forecasted to be very small, whereas the daily expected return is presently at 0.87%. %. The volatility of related hype on Nanhua Bio is about 1419.76%, with the expected price after the next announcement by competition of 10.35. About 13.0% of the company shares are owned by insiders or employees . The company recorded a loss per share of 0.12. Nanhua Bio Medicine last dividend was issued on the 23rd of April 2004. The entity had 13:10 split on the 15th of January 2007. Assuming the 90 days trading horizon the next forecasted press release will be in 5 to 10 days. Check out Nanhua Bio Basic Forecasting Models to cross-verify your projections.Nanhua Bio Related Hype Analysis
Having access to credible news sources related to Nanhua Bio's direct competition is more important than ever and may enhance your ability to predict Nanhua Bio's future price movements. Getting to know how Nanhua Bio's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Nanhua Bio may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| 603986 | GigaDevice SemiconductorBeiji | 0.00 | 0 per month | 2.63 | 0.01 | 6.82 | (4.63) | 15.40 | |
| 300481 | Puyang Huicheng Electronic | 0.89 | 1 per month | 3.02 | 0.09 | 6.84 | (4.08) | 25.02 | |
| 688469 | Semiconductor Manufacturing Electronics | (0.35) | 2 per month | 2.51 | 0.12 | 6.56 | (3.80) | 28.40 | |
| 002121 | Shenzhen Clou Electronics | 0.00 | 0 per month | 2.48 | 0.1 | 6.42 | (3.19) | 19.21 | |
| 605098 | Shanghai Action Education | 0.51 | 2 per month | 3.22 | (0.03) | 5.00 | (4.58) | 19.77 | |
| 688589 | Leaguer Shenzhen MicroElectronics | 1.46 | 1 per month | 3.06 | 0.05 | 6.43 | (5.30) | 27.59 | |
| 000785 | Easyhome New Retail | 0.02 | 1 per month | 2.60 | 0.04 | 4.44 | (3.45) | 16.47 | |
| 600757 | Changjiang Publishing Media | 0.00 | 0 per month | 2.41 | (0.02) | 2.70 | (2.49) | 16.12 |
Nanhua Bio Additional Predictive Modules
Most predictive techniques to examine Nanhua price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Nanhua using various technical indicators. When you analyze Nanhua charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Nanhua Bio Predictive Indicators
The successful prediction of Nanhua Bio stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Nanhua Bio Medicine, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Nanhua Bio based on analysis of Nanhua Bio hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Nanhua Bio's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Nanhua Bio's related companies.
Story Coverage note for Nanhua Bio
The number of cover stories for Nanhua Bio depends on current market conditions and Nanhua Bio's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Nanhua Bio is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Nanhua Bio's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
Nanhua Bio Short Properties
Nanhua Bio's future price predictability will typically decrease when Nanhua Bio's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Nanhua Bio Medicine often depends not only on the future outlook of the potential Nanhua Bio's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Nanhua Bio's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 330 M | |
| Dividends Paid | 2.3 M | |
| Shares Float | 153.5 M |
Complementary Tools for Nanhua Stock analysis
When running Nanhua Bio's price analysis, check to measure Nanhua Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nanhua Bio is operating at the current time. Most of Nanhua Bio's value examination focuses on studying past and present price action to predict the probability of Nanhua Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nanhua Bio's price. Additionally, you may evaluate how the addition of Nanhua Bio to your portfolios can decrease your overall portfolio volatility.
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules |